newsfilter
← Latest News
Business Wire·

Silence Therapeutics to Participate in Three September Investor Conferences

Silence Therapeutics plc (NASDAQ:SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in the following